VRCI — Verici Dx Income Statement
0.000.00%
- £12.11m
- £11.87m
- $3.34m
Annual income statement for Verici Dx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 1.01 | 3.34 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.057 | 8.33 | 11.5 | 9.88 | 9.45 |
| Operating Profit | -0.057 | -8.33 | -11.5 | -8.87 | -6.11 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.084 | -8.33 | -11.4 | -8.73 | -5.87 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.084 | -8.33 | -11.4 | -8.73 | -5.87 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.084 | -8.33 | -11.4 | -8.73 | -5.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.084 | -8.33 | -11.4 | -8.73 | -5.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.059 | -0.069 | -0.051 | -0.025 |
| Dividends per Share |